Efficacy and safety from this phase IV study were consistent with data from the Vabysmo phase III DME studies
MedGenome reaffirms its commitment to broaden access to quality and affordable genetic solutions for all
He will join in place of Anil Arora, current President- Formulations Operations who will be superannuating in November, 2024
Indoco is comprehensively working on the remedial action plan
Strokes are affecting approximately 1.8 million people annually
Wockhardt's yet another novel antibiotic Miqnaf receives favourable recommendation from Subject Expert Committee of CDSCO
SIBUR is developing a special grade of polycarbonate compatible with radiation sterilization
WHO estimates suggest that 150 million people worldwide are affected by Trachoma
We now rank 3rd in pharmaceutical production by volume and 14th by value
WEF recognises company’s Bharuch manufacturing facility as a global manufacturing lighthouse
Subscribe To Our Newsletter & Stay Updated
